Cite
HARVARD Citation
Bruni, C. et al. (n.d.). AB0281 SAFETY AND RETENTION RATE AFTER SWITCHING FROM ETANERCEPT ORIGINATOR (ETN) TO ETANERCEPT BIOSIMILAR (SB4) IN INFLAMMATORY JOINT DISEASES: DATA FROM REAL LIFE.. Annals of the rheumatic diseases. pp. 1439-1440. [Online].